Aggressive papillary thyroid microcarcinoma: Prognostic factors and therapeutic strategy

Clinical Nuclear Medicine

Volumn 38, Issue 1, 2013, Pages 25-28

  Ardito, Guglielmo ^a   Revelli, Luca ^a   Giustozzi, Erika ^a   Salvatori, Massimo ^b   Fadda, Guido ^a   Ardito, Francesco ^c   Avenia, Nicola ^d   Ferretti, Alice ^e   Rampin, Lucia ^e   Chondrogiannis, Sotirios ^e   Colletti, Patrick M ^f   Rubello, Domenico ^e  

^a Department of Endocrine Surgery ^*  (Italy)

^b Roma La Sapienza 2   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

^e SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

131I therapy; ggressive behavior; otal thyroidectomy; papillary thyroid microcarcinoma; rognostic factors

Indexed keywords

IODINE 131;

ADULT; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CAUSE OF DEATH; CERVICAL LYMPHADENOPATHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LUNG METASTASIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RADIOISOTOPE THERAPY; RECURRENCE RISK; RECURRENT CANCER; REOPERATION; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84871654075     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318279bc65     Document Type: Article

References (31)

1. Rosai J, Zampi G, Carcangiu ML. Papillary carcinoma of the thyroid: a discussion of its several morphologic expressions with particular emphasis on the follicular variant. Am J Surg Pathol. 1983;7:809-817. (Pubitemid 14222468)
2. De Groot LJ, Kaplan EL, McMormick M, et al. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990;71: 414-424.
3. Watson RG, Brennan MD, Goellner JR, et al. Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc. 1984;59: 851-855.
4. Hedinger C, Williams ED, Sobin LH. Histological Typing of Thyroid Tumours. 2nd ed. Verlag, Berlin: Springer; 1988.
5. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428. (Pubitemid 24345593)
6. Salvadori B, Del Bo R, Pilotti S, et al. "Occult" papillary carcinoma of the thyroid: a questionable entity. Eur J Cancer. 1993;29A:1817-1820. (Pubitemid 23288019)
7. Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992;112: 1139-1146.
8. Ardito G, Cavallaro A, Mantovani M, et al. Occult carcinoma of the thyroid. A changing pathology? J R Coll Surg Edinb. 1982;27:219-223.
9. Melliere D. Small thyroid nodules and microcancers. Press Med. 1995;24: 1552-1554.
10. Yamashita H, Noguchi S, Murakami M, et al. Extracapsular invasion of lymph node metastasis. Cancer. 1999;86:842-849.
11. Chow SM, Law SC, Chan JK, et al. Papillary microcarcinoma of the thyroidV prognostic significance of lymph node metastasis and multifocality. Cancer. 2003;98:31-40. (Pubitemid 36741122)
12. Noguchi S, Yamashita H, Murakami N, et al. Small carcinomas of the thyroid a long-term follow-up of 867 patients. Arch Surg. 1996;131:187-191. (Pubitemid 26053907)
13. Lo CY, Chan WF, Lang BH, et al. Papillary microcarcinoma: is there any difference between clinically overt and occult tumors? World J Surg. 2006; 30:759-766. (Pubitemid 43724103)
14. Besic N, Pilko G, Petric R, et al. Papillary thyroid microcarcinoma: prognostic factors and treatment. J Surg Oncol. 2008;97:221-225. (Pubitemid 351312160)
15. Kim TY, Hong SJ, Kim JM, et al. Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer. 2008;8:296.
16. Pisanu A, Reccia I, Nardello O, et al. Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg. 2009;33:460-468.
17. Baudin E, Travagli JP, Ropers J, et al. Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer. 1998;83:553-559. (Pubitemid 28354512)
18. Ardito G, Revelli L, Moschella F, et al. Diagnostic lobectomy for unilateral follicular nodules of the thyroid gland. Surg Today. 2004;34:557-559. (Pubitemid 38738480)
19. Roti E, degli Uberti EC, Bondanelli M, et al. Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol. 2008;159:659-673.
20. Barbaro D, Simi U, Meucci G, et al. Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancersVare they different diseases? Clin Endocrin. 2005;63:577-581. (Pubitemid 41626754)
21. Gulben K, Berberoglu U, Celen O, et al. Incidental papillary microcarcinoma of the thyroidVfactors affecting lymph node metastasis. Langenbecks Arch Surg. 2008;393:25-29. (Pubitemid 350196885)
22. Lin J-D, Chen S-T, Chao T-C, et al. Diagnosis and therapeutic strategy for papillary thyroid microcarcinoma. Arch Surg. 2005;140:940-945. (Pubitemid 41464457)
23. Roti E, Rossi R, Trasforini G, et al. Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrin Metab. 2006;91:2171-2178. (Pubitemid 43855001)
24. Sugitani I, Yanagisawa A, Shimizu A, et al. Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg. 1998;22:731-737. (Pubitemid 28277870)
25. Park YJ, Kim YA, Lee YJ, et al. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck. 2010;32: 38-45.
26. Mazzaferri EL. Managing thyroid microcarcinomas. Yonsei Med J. 2012; 53:1-14.
27. Cooper DS, Doherty GM, Haugen BR et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
28. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803. (Pubitemid 43997716)
29. British Thyroid Association and Royal College of Physicians. Guidelines for the management of thyroid cancer in adults. Available at: www.british-thyroidassociation. org. 2002. Accessed September 1, 2012.
30. Van den Bruel A, Moreno-Reyes R, Bex M, et al. Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines?Vresults of a national survey. Clin Endocrinol. 2008;68:599-604. (Pubitemid 351388714)
31. Pelizzo MR, Boschin IM, Toniato A, et al. Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol. 2006;32:1144-1148. (Pubitemid 44774404)